Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 4/20 | 0.53 |
| ▸ | NAAA | Q02083 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16881052 | 0.83 | GRM2 (0.53) | GRM2LTA4HALDH1A1POLBKCNH2 | |
| SCHEMBL5216969 | 0.83 | GRM2 (0.53) | GRM2NAAAFAAHLTA4HALDH1A1 | |
| SCHEMBL259624 | 0.83 | GRM2 (0.53) | GRM2NAAAFAAHLTA4HALDH1A1 | |
| SCHEMBL14002387 | 0.83 | SMN1; SMN2 (0.55) | GRM2NAAALTA4HALDH1A1POLB | |
| SCHEMBL531434 | 0.82 | GRM2 (0.52) | GRM2NAAAFAAHLTA4HPOLB | |
| SCHEMBL16610628 | 0.82 | GRM2 (0.50) | GRM2NAAAFAAHLTA4HALDH1A1 | |
| SCHEMBL14687303 | 0.82 | GRM2 (0.50) | GRM2NAAAFAAHLTA4HALDH1A1 | |
| SCHEMBL5248237 | 0.81 | GRM2 (0.49) | GRM2NAAAFAAHLTA4HALDH1A1 | |
| SCHEMBL4519506 | 0.81 | GRM2 (0.51) | GRM2NAAAFAAHLTA4HPOLB | |
| SCHEMBL30996376 | 0.79 | GRM2 (0.60) | GRM2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007029062-A2 | NOVEL PYRIDINE DERIVATIVES | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2007-03-15 | — | — | WO | disclosed |